In a report released on July 27, Ben Hendrix from RBC Capital maintained a Hold rating on Universal Health (UHS – Research Report), with a price target of $152.00. The company’s shares closed yesterday at $138.96.
Hendrix covers the Healthcare sector, focusing on stocks such as Community Health, CVS Health, and Ehealth. According to TipRanks, Hendrix has an average return of -0.6% and a 50.38% success rate on recommended stocks.
In addition to RBC Capital, Universal Health also received a Hold from Wells Fargo’s Steve Baxter in a report issued on July 27. However, on the same day, Credit Suisse maintained a Buy rating on Universal Health (NYSE: UHS).
See Insiders’ Hot Stocks on TipRanks >>
UHS market cap is currently $8.73B and has a P/E ratio of 14.40.
Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UHS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.
Read More on UHS:
- Universal Health price target raised to $169 from $163 at Credit Suisse
- Universal Health price target raised to $162 from $154 at UBS
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2023 SECOND QUARTER FINANCIAL RESULTS
- Universal Health raises FY23 adjusted EPS view to $9.85-$10.50 from $9.50-$10.50
- Universal Health reports Q2 adjusted EPS $2.53, consensus $2.43
